Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 8, Issue 5 (2019)

Prescription pattern analysis of antidiabetic drugs: A prospective study in OPD patients of medicine department at Bidar institute of medical sciences, Bidar

Author(s):
Dr. Chetan DB, Dr. Syed Sujat Pasha and Nayana R Sakre
Abstract:
Diabetes results from the failure of the pancreas to produce a sufficient amount of insulin. Hormone that regulates the body's use of glucose is insulin the pancreas produces a sufficient amount of insulin, but if the insulin is blocked from the body's cells and cannot be used. This causes patients to have abnormally high amounts of sugar in their urine and blood. Diagnosing a patient with diabetes is more complicated than measuring the glucose level of urine only one time. The diagnosis involves several hours of glucose-tolerance tests (GTT). A prospective observational study was carried out on 100 patients of both type 1 and 2 diabetes mellitus attending the OPD in BRIMS teaching hospital. Institutional ethics clearance was taken and the study conducted from Jan 2019 to march 2019. Data of 100 diabetic patients was collected and studied for the prescription pattern. In our study 30% were females and 70% were males. Most of the patients belong to the age group above 60 years (50%) followed by 40-60 years (40%). 95% patients had Type 2 Diabetes mellitus whereas type DM seen in 5% patients. The patients were either on monotherapy consisting of Insulin, metformin or sulphonyl urea or they were on combination therapy Out of 100 patients who were being studied, 76 % patients were on mono therapy, 16% patients prescribed dual therapy and only 8% were prescribed triple therapy.
Pages: 394-396  |  354 Views  55 Downloads


The Pharma Innovation Journal
How to cite this article:
Dr. Chetan DB, Dr. Syed Sujat Pasha, Nayana R Sakre. Prescription pattern analysis of antidiabetic drugs: A prospective study in OPD patients of medicine department at Bidar institute of medical sciences, Bidar. Pharma Innovation 2019;8(5):394-396.

Call for book chapter